Specgx Llc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CODEINE PHOSPHATE, with a corresponding US DMF Number 4839.
Remarkably, this DMF maintains an Active status since its submission on March 11, 1983, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 06, 2013, and payment made on February 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II